Bruker MALDI Biotyper™ Receives CFDA Clearance

News   Jun 26, 2014

 
Bruker MALDI Biotyper™ Receives CFDA Clearance
 
 
 

RELATED ARTICLES

Stable Beta-Amyloid Dimers Identified in Alzheimer’s Brains

News

A recent study exploited state-of-the-art mass spectrometry to provide the first direct evidence of beta-amyloid dimers in patients with Alzheimer’s disease and points to the potential of these molecules as biomarkers. Beta-amyloid dimers may be the smallest pathological species that trigger Alzheimer’s disease.

READ MORE

Detecting Heart Disease with an AI App

News

The process of assessing and monitoring heart disease, the leading cause of death in the US, is often expensive and time-consuming. A new app that incorporates pulse data to diagnose arterial changes could simplify the whole process.

READ MORE

A Fatal Attraction

News

Malaria causes the bodies of its human hosts to emit specific odours from the skin that make the hosts even more attractive to mosquitoes, perpetuating transmission. Researchers have now identified the odours as organic hydrocarbons heptanal, octanal and nonanal, whose discovery could bring relief to a disease that claimed nearly half a million lives in 2016.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE